These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22796097)

  • 21. Non-enzymatic glutathione reactivity and in vitro toxicity: a non-animal approach to skin sensitization.
    Aptula AO; Patlewicz G; Roberts DW; Schultz TW
    Toxicol In Vitro; 2006 Mar; 20(2):239-47. PubMed ID: 16112535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potency values from the local lymph node assay: application to classification, labelling and risk assessment.
    Loveless SE; Api AM; Crevel RW; Debruyne E; Gamer A; Jowsey IR; Kern P; Kimber I; Lea L; Lloyd P; Mehmood Z; Steiling W; Veenstra G; Woolhiser M; Hennes C
    Regul Toxicol Pharmacol; 2010 Feb; 56(1):54-66. PubMed ID: 19733604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive identification of human skin sensitization thresholds.
    Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
    Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals.
    Takenouchi O; Fukui S; Okamoto K; Kurotani S; Imai N; Fujishiro M; Kyotani D; Kato Y; Kasahara T; Fujita M; Toyoda A; Sekiya D; Watanabe S; Seto H; Hirota M; Ashikaga T; Miyazawa M
    J Appl Toxicol; 2015 Nov; 35(11):1318-32. PubMed ID: 25820183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The local lymph node assay and the assessment of relative potency: status of validation.
    Basketter DA; Gerberick F; Kimber I
    Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating skin sensitization potency from a single dose LLNA.
    Roberts DW
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):437-43. PubMed ID: 25625585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of an in vitro method to estimate the sensitization induction level of contact allergens.
    Galbiati V; Papale A; Marinovich M; Gibbs S; Roggen E; Corsini E
    Toxicol Lett; 2017 Apr; 271():1-11. PubMed ID: 28189648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The local lymph node assay compared with the human maximization test as an indicator of allergic potency in humans using patch test clinic populations.
    Zaghi D; Maibach HI
    Cutan Ocul Toxicol; 2009; 28(2):61-4. PubMed ID: 19514928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program.
    Aeby P; Ashikaga T; Bessou-Touya S; Schepky A; Gerberick F; Kern P; Marrec-Fairley M; Maxwell G; Ovigne JM; Sakaguchi H; Reisinger K; Tailhardat M; Martinozzi-Teissier S; Winkler P
    Toxicol In Vitro; 2010 Sep; 24(6):1465-73. PubMed ID: 20624454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing.
    Natsch A; Emter R; Ellis G
    Toxicol Sci; 2009 Jan; 107(1):106-21. PubMed ID: 18832184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin sensitization risk assessment model using artificial neural network analysis of data from multiple in vitro assays.
    Tsujita-Inoue K; Hirota M; Ashikaga T; Atobe T; Kouzuki H; Aiba S
    Toxicol In Vitro; 2014 Jun; 28(4):626-39. PubMed ID: 24444449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitivity of KeratinoSens
    Nishijo T; Miyazawa M; Saito K; Otsubo Y; Mizumachi H; Sakaguchi H
    J Toxicol Sci; 2019; 44(1):13-21. PubMed ID: 30626776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bayesian integrated testing strategy (ITS) for skin sensitization potency assessment: a decision support system for quantitative weight of evidence and adaptive testing strategy.
    Jaworska JS; Natsch A; Ryan C; Strickland J; Ashikaga T; Miyazawa M
    Arch Toxicol; 2015 Dec; 89(12):2355-83. PubMed ID: 26612363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Binary test battery with KeratinoSens™ and h-CLAT as part of a bottom-up approach for skin sensitization hazard prediction.
    Otsubo Y; Nishijo T; Miyazawa M; Saito K; Mizumachi H; Sakaguchi H
    Regul Toxicol Pharmacol; 2017 Aug; 88():118-124. PubMed ID: 28602621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intralaboratory validation of four in vitro assays for the prediction of the skin sensitizing potential of chemicals.
    Bauch C; Kolle SN; Fabian E; Pachel C; Ramirez T; Wiench B; Wruck CJ; van Ravenzwaay B; Landsiedel R
    Toxicol In Vitro; 2011 Sep; 25(6):1162-8. PubMed ID: 21669280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance.
    Teubner W; Mehling A; Schuster PX; Guth K; Worth A; Burton J; van Ravenzwaay B; Landsiedel R
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):468-85. PubMed ID: 24090701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
    McKim JM; Keller DJ; Gorski JR
    Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
    Gerberick GF; Ryan CA; Dearman RJ; Kimber I
    Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.